Green synthesis of CuO nanoparticles using Cassia auriculata leaf extract and in vitro evaluation of their biocompatibility with rheumatoid arthritis macrophages (RAW 264.7) by Shi, Long-Bao et al.
Shi et al 
Trop J Pharm Res, January 2017; 16(1): 185  
 
Tropical Journal of Pharmaceutical Research January 2017; 16 (1): 185-192 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v16i1.25 
Original Research Article 
 
 
Green synthesis of CuO nanoparticles using Cassia 
auriculata leaf extract and in vitro evaluation of their 
biocompatibility with rheumatoid arthritis macrophages 
(RAW 264.7) 
 
Long-Bao Shi, Pei-Fu Tang*, Wei Zhang, Yan-Peng Zhao, Li-Cheng Zhang and 
Hao Zhang 
Department of Orthopedic Surgery, The General Hospital of The People’s Liberation Army, Beijing 100853, China 
 
*For correspondence: Email: peifutang@hotmail.com 
 
Received: 3 September 2016        Revised accepted: 12 December 2016 
 
Abstract 
Purpose: To undertake green synthesis of copper oxide nanoparticles (CuO NPs) using Cassia 
auriculata leaf extract and evaluate their biocompatibility with rheumatoid arthritis macrophages (RAW 
264.7 cell line).  
Methods: CuO NPs were prepared by heating a mixture of 10 mL of 0.01 M CuSO4 solution and 30 mL 
of C. auriculata extract at 80 °C for 1 h. The synthesized CuO NPs were characterized by x-ray 
diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), ultraviolet-visible spectroscopy (UV-
Vis), energy-dispersive x-ray spectroscopy (EDS), scanning electron microscopy (SEM), transmission 
electron microscopy (TEM) and dynamic light scattering (DLS). The cytotoxicity of the NPs against RAW 
264.7 cells was studied using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay. 
Results: The gradual change in color of the reaction solution from brownish yellow to dark brown 
indicated CuO NP formation. TEM images revealed spherical, polydispersed NPs (mean particle size, 
23 nm). FTIR results indicated capping of polyphenols on the surface of the NPs. Most RAW 264.7 cells 
(> 95 %) remained alive following exposure to CuO NPs at concentrations of up to 200 μg/mL, indicating 
biocompatible with the cells. 
Conclusion: An eco-friendly, low-cost, biosynthetic method for CuO NP preparation has been 
successfully developed using C. auriculata leaf extract. Furthermore, the nanoparticles are 
biocompatible with RAW 264.7 cell line. 
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Copper oxide nanoparticles (CuO NPs) have 
attracted significant interest due to their wide 
variety of applications, including in catalysts, gas 
sensors, high-Tc superconductors, giant magnet 
resistance materials, solar energy devices, and 
in the preparation of organic-inorganic 
nanocomposites [1-5]. Additionally, CuO is used 
as an antifungal, antibiotic and antimicrobial 
agent when introduced into textiles and coatings 
[6]. 
 
Moreover, copper-related materials have 
demonstrated proficient biocidal properties, such 
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as those found in pesticide formulations [7]. 
Several methods are available for CuO NP 
preparation, namely, microwave irradiation [8], 
and sonochemical [9], electrochemical [10] and 
chemical reduction [11]. However, chemical 
synthesis of CuO leads to the adsorption of toxic 
chemicals on its surface, which may have 
harmful effects when used in biomedical 
applications. Hence, an environmentally friendly, 
cost-effective approach is required for CuO NP 
synthesis. Recently, biosynthesis of 
nanomaterials using green reducing agents and 
plants has been reported [12,13]. For example, 
nanomaterial biosynthesis with extracts of Albizia 
lebbeck [14], gum karaya [15], Aloe vera [16], 
and algae [17] has been demonstrated. 
 
The aim of the present work was to synthesize 
CuO NPs using dried clove extract of Cassia 
auriculata leaves and evaluate their in vitro 
cytotoxicity against RAW 264.7 cell line in order 







Copper sulfate (CuSO4), 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT), 
dimethyl sulfoxide (DMSO), potassium bromide 
(KBr), and other solvents were purchased from 
Sigma Aldrich Chemical Ltd., Shanghai, China.  
 
Preparation of plant extract 
 
Leaves of Cassia auriculata were collected from 
a plant located near the General Hospital of the 
People’s Liberation Army (No. 28, Fuxing Road, 
Haiding District, Beijing 100853, China). 
Approximately 2 g of dried C. auriculata leaves 
were added to 30 mL of double-distilled water 
and heated in a water bath for about 2 h at 90°C. 
The solution was filtered to obtain a clear 
solution of C. auriculata extract. 
 
Synthesis of CuO nanoparticles 
 
An amount (10 mL) of 0.01 M CuSO4 
solution was added to 30 mL of  
aqueous C. auriculata extract and mixed 
well with mechanical shaking. The 
solution was then heated in a water bath 
at 80 °C for 1 h. The gradual change of 
color of the reaction solution from 
brownish yellow to dark brown indicated 
the formation of CuO NPs. 
 
In vitro cytotoxicity test 
 
RAW 264.7 cells procured from the 
American Type Culture Collection were 
initially cultured in RPMI1640 medium 
containing 1% (w/v) penicillin–
streptomycin and 10% (v/v) fetal bovine 
serum (FBS) at 37°C in a 5 % CO2 
atmosphere. For cytotoxicity evaluation, 
the cells were initially seeded at 1 × 104 
cells per well in 96-well titer plates. Cell 
growth proceeded for 24 h. After two 
cycles of washing with phosphate buffer 
solution (PBS; pH: 7.4), various 
concentrations of CuO NPs were added 
to each well and incubated for 24 h. After 
the incubation period, the cells were 
washed twice with PBS, followed by the 
addition of fresh culture medium. About 
20 μL of MTT reagent (5 mg/mL in PBS) 
was then added to each well and further 
incubated for 4 h at 37 °C. The medium 
in each well was then discarded and 
DMSO was added to dissolve the cells. 
The optical density of each well was 





XRD analysis was performed using a 
Bruker D8 Advance diffractometer with 
Cu-Kα radiation (λ = 1.54 Å) and a step 
size of 0.02° over the range from 10–80° 
at a scan rate of about 4°/min. FTIR 
analysis of the prepared CuO NPs was 
carried out with a Jasco system to 
evaluate surface capping. A purified 
sample was dried and mixed well with 
KBr powder for pellet preparation for 
FTIR measurements. The surface 
morphology and size of the synthesized 
CuO NPs were analyzed using a high-
resolution transmission electron 
microscope (JEOL JEM 2100 HR-TEM). 
The sample for TEM analysis was 
prepared by placing a diluted CuO 
nanocolloid on the copper grid surface, 
which was later dried under a vacuum. 
Additionally, the surface charge and size 
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distribution of the CuO NPs were 
examined using a Horiba Scientific SZ-
100 Nanoparticle Analyzer. Samples for 
zeta potential analysis were prepared by 
diluting the CuO NPs with double-




The results are presented as mean ± 
standard deviation (SD). Statistical and 
analytical comparisons of the data were 
conducted using Student’s t-test or one-
way analysis of variance (ANOVA). P < 





The UV–Vis spectra of aqueous dispersed CuO 
exhibited a strong surface plasmon resonance 
(SPR) absorption band at 285 nm, signifying the 
formation of CuO NPs. No optical absorption 
peak was observed in the UV-Vis spectra of the 




Figure 1: Ultraviolet-visible absorption spectrum 
of the synthesized CuO nanoparticles (CuO NPs) 
 
The characteristic XRD peaks observed for CuO 
NPs prepared using C. auriculata extract are 
shown in Figure 2. Intense diffraction peaks at 
32.54°, 35.56°, 38.77°, 48.74°, 53.53°, 58.37°, 
61.56°, 66.29° and 68.17°, corresponding to 110, 
0 02, 111, 202, 020, 202,113, 311 and 113 
planes, respectively, indicated the formation of a 
typical monoclinic CuO NP structure without 
impurities. Sharp, well-defined CuO reflections in 
the XRD pattern confirmed the highly crystalline 
nature of the as-prepared CuO NPs (JCPDS 
card no. 801268). 
 
Figure 3 shows field-emission SEM (FE-SEM) 
and high-resolution TEM (HRTEM) images of the 
biosynthesized CuO NPs; spherical CuO NP 
formation was revealed. The average particle 
size as indicated by TEM was 23.17 nm, in good 
agreement with the DLS results. The EDS 
spectrum of the CuO NPs showed the presence 
of O and Cu peaks only; there was no evidence 




Figure 2: X-ray diffraction pattern of Cassia auriculata extract-mediated synthesized CuO NPs 
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Figure 3: Field-emission scanning electron microscopy (a) and high-resolution transmission electron 
microscopy image (b) of Cassia auriculata extract-mediated synthesized CuO NPs 
 
 
Figure 4: Energy-dispersive X-ray spectroscopy spectrum of Cassia auriculata extract-mediated 
synthesized CuO NPs 
 
Additionally, DLS analysis was carried out to 
determine the size distribution of the formed CuO 
NPs. From Fig. 5A, the average particle size of 
the CuO NPs was 22.4 nm. Zeta potential 
analysis showed a negative surface zeta 
potential of −25.4 mV (Fig. 5B). It is well known 
that the surface charge and size distribution play 
key roles in the biological activity of prepared 
NPs. 
 
Figure 5 shows the presence of bands in the 
FTIR spectrum of CuO NPs at 3385, 1612, and 
1033 cm−1 corresponding to hydroxyl group (-
OH) stretching, hydroxyl (-OH) bending, and C-O 
stretching, respectively. Additionally, the 
presence of bands at 2922 and 1720 cm−1 is 
associated with C-H stretching and ketone group 
vibrations. The bands at 600 and 668 cm−1 are 




The formation of CuO NPs was indicated by the 
presence of a dark brown precipitate in the 
bottom of the flask. The Cassia auriculata extract 
filtrate containing 0.5 M CuSO4 solution began to 
change color 30 min into the reaction and turned 
completely dark brown after 1 h. A control 
experiment performed without the addition of 
plant extract did not show color change or 
evidence of CuO NP formation. 
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Figure 5: Dynamic light scattering (A) and zeta potential (B) analysis of Cassia auriculata extract-




Figure 6: Fourier-transform infrared spectrum of Cassia auriculata extract-synthesized CuO NPs 
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Figure 7: In vitro cytotoxicity of Cassia auriculata extract-mediated synthesized CuO NPs; the error 
bars in the graph represent standard deviation (n = 3) 
 
The UV-Vis absorption spectrum confirmed CuO 
NP formation, showing a characteristic SPR 
band at 285 nm. SPR in the CuO NPs was 
attributed to the collective oscillation of free 
surface conduction electrons, excited by the 
incident electromagnetic radiation. XRD, EDS, 
TEM analyses indicated the crystalline nature of 
the plant extract-mediated synthesized CuO 
NPs. The EDS spectrum confirmed the presence 
of copper and oxygen; smaller peaks were 
attributed to biomolecules present in the extract 
solution. These results are similar to those of 
previous studies in which green synthesized CuO 
NPs were prepared using sublimated precursors 
[18,19]. 
 
Furthermore, the zeta potential of the as-
synthesized CuO NPs indicated a negative 
surface charge, which may have been due to the 
stabilization of the biomolecular constituents of 
Cassia auriculata extract on the surface of the 
formed NPs after the reduction process. The 
negative surface charge of the synthesized CuO 
NPs further leads to the generation of strong 
electrostatic repulsion forces among the NPs; 
this stabilizes the NPs by reducing their 
aggregation. Notably, the negative surface 
charge of NPs fabricated using plant extracts has 
been reported in the literature [20]. 
 
The FTIR spectrum of the CuO NPs 
showed the existence of C-O and 
hydroxyl functionalities on the NP 
surface. The FTIR band present at 1720 
cm−1 corresponded to ketone functional 
groups of oxidized polyphenols in the 
extract of Cassia auriculata, signifying 
that the synthesized CuO NPs are 
capped by oxidized polyphenols. 
Additionally, the stretching bands at 600 
and 668 cm−1 are related to Cu-O 
absorption, further indicating CuO NP 
formation. These results indicate that the 
synthesized CuO NPs are stabilized by 
biomolecular constituents present in the 
extract of Cassia auriculata. 
 
Macrophages play an important role in 
rheumatoid arthritis. Synovial fibroblasts 
along with microphages are involved in 
the production of a number of matrix-
degrading enzymes, chemokines, and 
cytokines that mediate the interaction 
with endothelial and inflammatory cells. 
Subsequently, they are accountable for 
the successive destruction of bone and 
articular cartilage, taking into 
consideration the fact that synovial 
fibroblasts and macrophages mediate 
the most significant pathway of joint 
destruction. Hence, these macrophages 
would be important targets in current 
therapeutic approaches to reducing the 
destruction of bone and cartilage in 
rheumatoid arthritis [21,22]. In this 
regard, we have studied the cell viability 
of RAW 264.7 cell lines after their 
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treatment with CuO NPs to examine the 
ability of the prepared NPs for drug 
delivery during the treatment of 
rheumatoid arthritis. 
 
To study the cytotoxicity of prepared CuO NPs, 
RAW 264.7 macrophage cell lines were 
incubated with different concentrations of NPs. 
Most of the cells (> 95 %) remained alive after 
exposure to a CuO NP concentration of up to 
200 μg/mL, signifying their low cytotoxicity. Thus, 
CuO NPs prepared using C. auriculata extract 
may be suitable as a drug delivery vehicle for 





An eco-friendly, low-cost biosynthetic method for 
the preparation of CuO NPs using Cassia 
auriculata leaf extract is presented in this work. 
The Cassia auriculata extract-mediated CuO 
NPs exhibit very low cytotoxicity towards RAW 
264.7 cell lines, thus indicating their 
biocompatibility with the cells and potential 
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